Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma 19Fibrosarcoma 8Leiomyosarcoma 7Sarcoma, Synovial 6Rhabdomyosarcoma 6Neurofibrosarcoma 6Lymphoma 6Liposarcoma 6Histiocytoma, Malignant Fibrous 6Hemangiosarcoma 6Osteosarcoma 5Neuroectodermal Tumors, Primitive, Peripheral 5Malignant mesenchymal tumor 5Hemangiopericytoma, Malignant 5Burkitt Lymphoma 4Testicular Neoplasms 3Teratoma 3Sarcoma, Ewing 3Sarcoma, Alveolar Soft Part 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Ovarian Neoplasms 3Lymphoma, Large B-Cell, Diffuse 3Hodgkin Disease 3Carcinoma, Embryonal 3Wilms Tumor 2Sarcoma, Endometrial Stromal 2Pheochromocytoma 2Neuroblastoma 2Neoplasm Metastasis 2Leukemia 2

Interventions

Razoxane 4Doxorubicin 4Dexrazoxane 4Vincristine 3Etoposide 3Radiotherapy 2Prednisone 2Methotrexate 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2Bleomycin 2hydrocortisone hemisuccinate 1Watchful Waiting 1Trastuzumab 1Proton Therapy 1Observation 1Mercaptopurine 1Leucovorin 1Ifosfamide 1Hydrocortisone 1Enalapril 1Cytarabine 1Cyclophosphamide 1Cisplatin 1Carvedilol 1Asparaginase 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Cardiotoxicity × Ifosfamide × Clear all
NCT00003937 2014-08-05

Combination Chemotherapy Plus Dexrazoxane in Treating Patients With Newly Diagnosed Nonmetastatic Osteosarcoma

Children's Oncology Group

Phase 3 Completed
253 enrolled
Sarcoma

Sarcoma, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡